Immunome, Inc.: Piper Sandler cuts target price to $30 from $33
IMNM•Piper Sandler cut its target price for Immunome, Inc. to $30 from $33.
Related News
EOG Resources: Susquehanna raises target price to $196 from $187
EOG•
Booz Allen Hamilton files initial beneficial ownership statement for executive vice president John Bradley Medairy
BAH•
Oil falls as Trump downplays prospect of escalation with Iran
USO•
Aussie steadies as oil-fuelled risk rally offsets weak domestic surveys
TLT•
Qualys, Inc.: Piper Sandler raises target price to $185 from $175
QLYS•